Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
linkNovel natural killer cell-based therapies for hematologic and solid malignancies: latest updates from ASCO 2024
linkNK Cell Therapy: A Rising Star in Cancer Treatment
linkDevelopment of NK cell-based cancer immunotherapies through receptor engineering
linkNK cell-based immunotherapy for malignant diseases
linkA historical and contemporary perspective
linkNK cell-based cancer immunotherapy: from basic biology to clinical development
linkAdvantages and clinical applications of natural killer cells in cancer immunotherapy
linkNK Cell-Based Immunotherapies in Cancer
link